163 related articles for article (PubMed ID: 2654146)
1. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design.
Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T
J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
Kam CM; Fujikawa K; Powers JC
Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
4. Substituted isocoumarins as inhibitors of complement serine proteases.
Kam CM; Oglesby TJ; Pangburn MK; Volanakis JE; Powers JC
J Immunol; 1992 Jul; 149(1):163-8. PubMed ID: 1607651
[TBL] [Abstract][Full Text] [Related]
5. Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.
Harper JW; Powers JC
Biochemistry; 1985 Dec; 24(25):7200-13. PubMed ID: 3910097
[TBL] [Abstract][Full Text] [Related]
6. The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors.
Hudig D; Allison NJ; Pickett TM; Winkler U; Kam CM; Powers JC
J Immunol; 1991 Aug; 147(4):1360-8. PubMed ID: 1869829
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC
J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707
[TBL] [Abstract][Full Text] [Related]
8. Coumarin and isocoumarin as serine protease inhibitors.
Pochet L; Frédérick R; Masereel B
Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
[TBL] [Abstract][Full Text] [Related]
9. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor.
Harper JW; Hemmi K; Powers JC
Biochemistry; 1985 Apr; 24(8):1831-41. PubMed ID: 3893537
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process.
Wei L; Lai Z; Gan X; Alliston KR; Zhong J; Epp JB; Tu J; Perera AB; Van Stipdonk M; Groutas WC
Arch Biochem Biophys; 2004 Sep; 429(1):60-70. PubMed ID: 15288810
[TBL] [Abstract][Full Text] [Related]
11. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
[TBL] [Abstract][Full Text] [Related]
12. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
[TBL] [Abstract][Full Text] [Related]
13. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
15. Proteases--structures, mechanism and inhibitors.
Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
[TBL] [Abstract][Full Text] [Related]
16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
17. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
18. Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidinoisocoumarin.
Powers JC; Oleksyszyn J; Narasimhan SL; Kam CM
Biochemistry; 1990 Mar; 29(12):3108-18. PubMed ID: 2337582
[TBL] [Abstract][Full Text] [Related]
19. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
